<SEC-DOCUMENT>0001062993-25-004083.txt : 20250303
<SEC-HEADER>0001062993-25-004083.hdr.sgml : 20250303
<ACCEPTANCE-DATETIME>20250303151757
ACCESSION NUMBER:		0001062993-25-004083
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20250303
FILED AS OF DATE:		20250303
DATE AS OF CHANGE:		20250303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ORGANIGRAM HOLDINGS INC.
		CENTRAL INDEX KEY:			0001620737
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			Z4
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38885
		FILM NUMBER:		25697199

	BUSINESS ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3
		BUSINESS PHONE:		506-384-1571

	MAIL ADDRESS:	
		STREET 1:		35A ENGLISH DR.
		CITY:			MONCTON
		STATE:			A3
		ZIP:			E1E 3X3

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORGANIGRAM HOLDINGS INC
		DATE OF NAME CHANGE:	20140926
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>form6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Form 6-K - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 18pt;"><b>UNITED STATES</b></font></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><font style="font-size: 18pt;"><b>SECURITIES AND EXCHANGE COMMISSION</b></font></p>
    <p style="margin-top: 0pt; text-align: center;"><b>Washington, D.C. 20549</b></p>
    <p style="text-align: center;"><font style="font-size: 18pt;"><b>FORM 6-K</b></font></p>
    <p style="text-align: center;"><b>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</b></p>
    <p style="text-align: center;">For the month of <b><u>March 2025</u></b></p>
    <p style="text-align: center;">Commission File Number: <u><b>001-38885</b></u></p>
    <p style="margin-bottom: 0pt; text-align: center;"><font style="font-size: 18pt;"><u><b>ORGANIGRAM HOLDINGS INC.</b></u></font></p>
    <p style="margin-top: 0pt; text-align: center;">(Translation of registrant's name into English)</p>
    <p style="margin-bottom: 0pt; text-align: center;"><b>145 King Street West, Suite 1400</b></p>
    <p style="margin-top: 0pt; margin-bottom: 0pt; text-align: center;"><u><b>Toronto, Ontario ,Canada M5H 1J8</b></u></p>
    <p style="margin-top: 0pt; text-align: center;"><b> </b>(Address of principal executive offices)</p>
    <p style="text-align: justify;">Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.</p>
    <p style="text-align: center;">Form 20-F [&#160; ]<font style="display: inline-block; width: 48.26pt;">&#160;</font>&#160; <b>Form 40-F [ X ]</b></p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):&#160; [&#160; ]</p>
    <p style="text-align: justify;">Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):&#160; [&#160; ]</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: center;"><b>SUBMITTED HEREWITH</b></p>
    <p style="text-align: justify;"><u><b>Exhibits</b></u></p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" cellspacing="0" cellpadding="0">
        <tr>
            <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #eeeeee; width: 10%;"><a href="exhibit99-1.htm">99.1</a></td>
            <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #eeeeee; width: 90%;"><a href="exhibit99-1.htm">News Release dated March 3, 2025</a></td>
        </tr>
    </table>
    <br>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: center;"><b>SIGNATURE</b></p>
    <p style="text-align: justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</p>
    <p style="text-align: justify;"><b>ORGANIGRAM HOLDINGS INC.</b></p>
    <p style="text-align: justify;">&#160;</p>
    <table style="width: 100%; border-collapse: collapse; font-size: 10pt;" border="0" cellspacing="0" cellpadding="0">
        <tr>
            <td style="width: 50%; border-bottom: 0.75pt solid #000000;">/s/ Greg Guyatt</td>
            <td style="width: 50%;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 50%;">Greg Guyatt</td>
            <td style="width: 50%;">&#160;</td>
        </tr>
        <tr>
            <td style="width: 50%;">Chief Financial Officer</td>
            <td style="width: 50%;">&#160;</td>
        </tr>
    </table>
    <p style="text-align: justify;">Date: March 3, 2025</p>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>

<head>
    <title>OrganiGram Holdings Inc.: Exhibit 99.1 - Filed by newsfilecorp.com</title>
</head>

<body style="font-size:10pt; font-family:'Times New Roman';">
    <hr width="100%" size="3" color="black" noshade="noshade"><a name="page_1"></a>
    <p style="text-indent: 18pt; text-align: center;"><font style="font-size: 14pt;"><font style="color: #222222; background-color: #ffffff;"><b>Organigram Closes Third Tranche of Previously Announced </b></font><font style="color: #222222;"><b>BAT Private Placement Investment</b></font></font></p>
    <p style="text-indent: 18pt; text-align: center;"><img src="exhibit99-1x001.jpg" style="width: 237px;" height="237"></p>
    <p style="text-align: justify;"><b>TORONTO, Ontario</b> - March 3, 2025 - <font style="color: #212529; background-color: #ffffff;">Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), (the "<b>Company</b>" or "<b>Organigram</b>"), a leading licensed producer of cannabis,</font> announced today that on February 28, 2025, the Company closed the third and last of three tranches (the "<b>Third Tranche</b>") of the previously announced C$124,559,674 follow-on strategic equity investment (the "<b>Investment</b>") by BT DE Investments Inc. (the "<b>Investor</b>"), a wholly owned subsidiary of British American Tobacco plc ("<b>BAT</b>"). Pursuant to the Third Tranche closing, the Investor acquired 7,562,447 common shares (the "<b>Common Shares"</b>) and 5,330,728 Class A preferred shares (the "<b>Preferred Shares</b>" and together with the Common Shares, the "<b>Shares</b>") of the Company at a price of C$3.2203 per Share (the "<b>Per Share Price</b>") for gross proceeds of USD$28,955,918.44 (equal to C$41,519,891)<a name="_ftnref1"></a><a style="text-decoration: none;" href="#_ftn1"><font style="color: #000000;"><sup>1</sup></font></a>.</p>
    <p style="text-align: justify;">"With all three tranches of the Jupiter private placement now funded, Organigram has approximately C$57.8 million to further invest from its Jupiter strategic investment pool after completing investments of C$21 million in Sanity Group and C$2.7 million in Open Book Extracts," said Paolo De Luca, Chief Strategy Officer of Organigram. "Opportunities in the space have only improved with cannabis valuations at historically weaker levels and many cannabis and hemp companies unable to access cost-efficient growth capital despite fundamentally strong businesses. We look forward to continuing to roll out our international and differentiated product strategy supported by the Jupiter platform."</p>
    <p style="text-align: justify;">As previously announced, most of the Investment is being used by Organigram to fund a strategic investment pool, named "Jupiter" (the "<b>Jupiter Pool</b>"). The Jupiter Pool was designed to accelerate Organigram's international growth ambitions and targets investments both overseas and in the United States. All potential investments will undertake rigorous legal compliance and due diligence processes.</p>
    <p style="text-align: justify;"><b>Early Warning Disclosure</b></p>
    <p style="text-align: justify;">Immediately following the closing of the Third Tranche, the Investor beneficially owned 40,134,389 Common Shares and 13,794,163 Preferred Shares, representing 30% of the issued and outstanding Common Shares and 100% of the Preferred Shares, in each case on a non-diluted basis.</p>
    <p style="text-align: justify;">As previously announced, the Investment was undertaken in three (3) tranches, each subject to the satisfaction of certain conditions. Under the first tranche (the "<b>First Tranche</b>"), which closed on January 23, 2024, 12,893,175<b> </b>Common Shares were issued to the Investor at the Per Share Price. Under the second tranche (the "<b>Second</b> <b>Tranche</b>"), which closed on August 30, 2024, 4,429,740<b> </b>Common Shares and 8,463,435<b> </b>Preferred Shares were issued to the Investor at the Per Share Price.</p>
    <p style="text-align: justify; margin-bottom: 0pt;">____________________________</p>
    <div id="ftn_page_1">
        <div id="_ftn1">
            <p style="text-align: justify; margin-top: 0pt;"><a style="text-decoration: none;" href="#_ftnref1"><font style="color: #000000;"><sup>1</sup></font></a> As determined using the average daily exchange rate published by the Bank of Canada on February 26, 2025 for converting Canadian dollars into U.S. dollars, being CAD$1.00 equals USD$0.6974.</p>
        </div>
    </div>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_2"></a>
    <p style="text-align: justify;">Approval by the Company's shareholders, clearance under the <i>Competition Act</i> (Canada), applicable stock exchange approval and certain other conditions to closing of each of the First Tranche, the Second Tranche and the Third Tranche were satisfied in connection with the closing of the First Tranche. The aggregate subscription price of the Shares acquired by the Investor as part of the First Tranche, the Second Tranche, and the Third Tranche was C$124,559,674.36.</p>
    <p style="text-align: justify;">Pursuant to the terms of the subscription agreement between the Investor and the Company dated November 5, 2023, as amended pursuant to an amending agreement dated December 20, 2023 (the "<b>Subscription Agreement</b>"), Shares issued in the First Tranche, the Second Tranche, and the Third Tranche were allocated between Common Shares and Preferred Shares, such that if the number of Common Shares owned by the Investor or its affiliates, associates, related parties and any joint actors would have exceeded 30% of the aggregate number of Common Shares issued and outstanding (the "<b>30% Threshold</b>") after the closing of the applicable tranche, the Company issued to the Investor the greatest number of Common Shares issuable pursuant to such closing without exceeding the 30% Threshold, with the remainder of the Shares issuable as Preferred Shares (all as more specifically set forth in the Subscription Agreement).</p>
    <p style="text-align: justify;">The Preferred Shares are non-voting convertible preferred shares of the Company convertible at the option of the Investor without payment of any additional consideration (subject to the 30% Threshold). The Preferred Shares are convertible initially on a one-for-one basis into Common Shares, provided however that the conversion rate will increase at a rate of 7.5% per annum commencing from the initial date on which Preferred Shares are issued, until such time as the holders of Preferred Shares would beneficially own, or exercise control or direction over, directly or indirectly, with their respective affiliates, associates, related parties and any joint actors, after giving effect to the conversion of the Preferred Shares, 49.0% of the aggregate number of Common Shares issued and outstanding.</p>
    <p style="text-align: justify;">The Investor entered into the Subscription Agreement in furtherance of its strategic investment in the Company. The Investor intends to review its investment in the Company on a continuing basis and may, subject to the terms of the A&amp;R Investor Rights Agreement (as defined below), and depending upon a number of factors, including market and other conditions, increase or decrease<b> </b>its<b> </b>beneficial ownership, control, direction or economic exposure over securities of the Company, through market transactions, private agreements, treasury issuances, exercise of options, convertible securities, derivatives, swaps or otherwise. Pursuant to the Subscription Agreement, unless otherwise consented to in writing by the Investor in advance, the Company is required to use one-half of the proceeds from each of the First Tranche and the Second Tranche for general corporate purposes, and one-half of the proceeds of each of the First Tranche and the Second Tranche, and all of the proceeds of the Third Tranche, to fund the Jupiter<b> </b>Pool, subject to adjustment in accordance with the terms of the Subscription Agreement. The Jupiter Pool is to be invested by the Company in accordance with the terms of reference provided for in the A&amp;R Investor Rights Agreement.</p>
    <p style="text-align: justify;">Pursuant to the amended and restated investor rights agreement entered into between the Investor and the Company concurrently with the closing of the First Tranche (the "<b>A&amp;R Investor Rights Agreement</b>"), the Investor has the right to nominate up to 30% of the board of directors of the Company (the "<b>Board</b>"), subject to the Investor maintaining certain share ownership thresholds. The Investor is entitled, subject to the terms and conditions of its nomination rights, to replace its nominee directors from time to time. In addition, the Investor has certain governance rights, so long as it maintains certain share ownership thresholds, including pre-emptive rights, top-up rights and customary registration rights. The Investor is permitted to engage with the Board regarding the Company's business and prospects.</p>
    <p style="text-align: justify;">This press release is being issued, in part, pursuant to National Instrument 62-103 - <i>The Early Warning System and Related Take-Over Bid and Insider Reporting Issues</i>, which requires an early warning report to be filed under the Company's profile on SEDAR+ at <font style="color: #0563c1;"><u>www.sedarplus.ca</u></font> containing additional information respecting the foregoing matters. You may also contact the Investor's media centre at +44 (0) 20 7845 2888, Victoria Buxton at +44 (0) 20 7845 2012 or Amy Chamberlain at +44 (0) 20 7845 1124 to obtain a copy of the early warning report once filed.</p>
    <p style="text-align: justify;">Further details relating to the Investment can be found in the press release issued by the Company on November 6, 2023 and the<font style="color: #212529;"> Company's management information circular dated December 20, 2023</font> (the "<b>Circular</b>").</p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_3"></a>
    <p style="text-align: justify;"><b>About Organigram Holdings Inc.</b></p>
    <p style="text-align: justify; background-color: #ffffff;">Organigram Holdings Inc. is a NASDAQ Global Select Market and TSX listed company whose wholly owned subsidiaries include Organigram Inc., a licensed cultivator of cannabis and manufacturer of cannabis-derived goods in Canada, and Motif Labs Ltd., a licensed cannabis processor.</p>
    <p style="text-align: justify; background-color: #ffffff;">Organigram is focused on producing high-quality cannabis for adult recreational consumers, as well as developing international business partnerships to extend the Company's global footprint. Organigram has also developed and acquired a portfolio of legal adult-use recreational cannabis brands, including Edison, Holy Mountain, Big Bag O' Buds, SHRED, SHRED'ems, Monjour, Tremblant Cannabis, Trailblazer, BOXHOT and DEBUNK. Organigram operates facilities in Moncton, New Brunswick and Lac-Sup&#233;rieur, Quebec, with a dedicated edibles manufacturing facility in Winnipeg, Manitoba. <font style="color: #212529;">The Company also operates two additional cannabis processing facilities in Southwestern Ontario; one in Aylmer and the other in London. The facility in Aylmer houses best-in-class </font><font style="color: #212529;">CO2 and Hydrocarbon</font><font style="color: #212529;"> extraction capabilities, and is optimized for formulation refinement, post-processing of minor cannabinoids, and pre-roll production. The facility in London will be optimized for labelling, packaging, and national fulfillment. </font>The Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada).</p>
    <p style="text-align: justify;"><b>Forward-Looking Information</b></p>
    <p style="text-align: justify; background-color: #ffffff;"><font style="color: #212529;">This news release contains forward-looking information. Often, but not always, forward-looking information can be identified by the use of words such as "plans", "expects", "estimates", "intends", "anticipates", "believes" or variations of such words and phrases or state that certain actions, events, or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-looking information involves known and unknown risks, uncertainties and other factors that may cause actual results, events, performance or achievements of Organigram to differ materially from current expectations or future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information include factors and risks disclosed in the Circular, and the Company's most recent annual information form, management's discussion and analysis and other Company documents filed from time to time on SEDAR+ (see www.sedarplus.ca) and filed or furnished to the Securities and Exchange Commission on EDGAR (see </font><font style="color: #1a3b5d;"><u>www.sec.gov</u></font><font style="color: #212529;">). Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Although the Company believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information and no assurance can be given that such events will occur in the disclosed time frames or at all. The forward-looking information included in this news release are made as of the date of this news release and the Company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking information, whether as a result of new information, future events or otherwise.</font></p>
    <hr style="page-break-after: always; text-align: center;" width="100%" size="5" color="black" noshade="noshade"><a name="page_4"></a>
    <p style="text-align: justify; background-color: #ffffff;"><font style="color: #212529;"><b>For </b></font><font style="color: #212529;"><b>Media</b></font><font style="color: #212529;"><b> enquiries: </b></font></p>
    <p style="background-color: #ffffff; text-align: justify;"><font style="color: #212529;">Megan McCrae, Senior Vice President - Global Brands and Corporate Affairs<br></font><font style="color: #0563c1;"><u>megan.mccrae@organigram.ca</u></font><font style="color: #212529;">&#160; </font></p>
    <p style="background-color: #ffffff; text-align: justify;"><font style="color: #212529;"><b>For </b></font><font style="color: #212529;"><b>Investor Relations</b></font><font style="color: #212529;"><b> enquiries: </b></font></p>
    <p style="background-color: #ffffff; text-align: justify;"><font style="color: #212529;">Max Schwartz, Director of Investor Relations </font><br><font style="color: #0563c1;"><u>investors@organigram.ca</u></font><font style="color: #212529;">&#160; </font></p>
    <div><br></div>
    <hr width="100%" size="5" color="black" noshade="noshade">
</body>

</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>exhibit99-1x001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 exhibit99-1x001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" #M .T# 2(  A$! Q$!_\0
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MB82F$8KT?P#8/K'A^UT>/05OM457N;.PG#QMJMOO;=]GD3:_FJRN-I+!@#M
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MYWOK8X(KZ2_X)JQ^7)XV]_[/_P#;FO(XHC;*:O\ V[_Z4CW^$J_/FM)?XO\
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M:22?_;K?_MQI:+IW@8D-'/?'_@)KKM%LO":[=DMU^(_^M6+I&KZEP#;6N/\
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MFXO+Z41QKV'JS'LH&23V KTZM&FX)7V/.I5JBFW;<^@/@7HH^('BC[+;-/\
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M6N4\<>(_%?AWQGJF@KXMUBX73KR2W$IO)%+[6(SC<<9Q4N&MKC3TV/H'XA>
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>^"<,:QGQEM'7[!_[<UABY7P\OE^9MAHVK1_KH?_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
